Ospemifene

Basic Information

Item Value
DrugBank ID DB04938
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 leprosy KG + DL
2 pulmonary hypertension KG + DL
3 kyphoscoliotic heart disease KG + DL
4 migraine with or without aura, susceptibility to KG + DL
5 migraine disorder KG + DL
6 migraine with brainstem aura KG + DL
7 nephrogenic syndrome of inappropriate antidiuresis KG + DL
8 rheumatoid arthritis KG + DL
9 atrophoderma vermiculata KG + DL
10 ulerythema ophryogenesis KG + DL
11 brachydactyly-syndactyly syndrome KG + DL
12 coronary artery disease KG + DL
13 pulmonary hypertension, primary, autosomal recessive KG + DL
14 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
15 hypertrichosis (disease) KG + DL
16 persistent Mullerian duct syndrome KG + DL
17 anomalous left coronary artery from the pulmonary artery KG + DL
18 obsolete patella aplasia, coxa vara, and tarsal synostosis KG + DL
19 Ambras type hypertrichosis universalis congenita KG + DL
20 malformation syndrome with odontal and/or periodontal component KG + DL
21 syndrome with a Dandy-Walker malformation as major feature KG + DL
22 multiple endocrine neoplasia KG + DL
23 coxopodopatellar syndrome KG + DL
24 idiopathic pulmonary arterial hypertension KG + DL
25 isolated genetic hair shaft abnormality KG + DL
26 chromosome 17q23.1-q23.2 deletion syndrome KG + DL
27 cor pulmonale KG + DL
28 myocardial ischemia KG + DL
29 familial clubfoot due to 17q23.1q23.2 microduplication KG + DL
30 pulmonary hypertension, primary KG + DL
31 genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability KG + DL
32 allergic asthma KG + DL
33 hyperargininemia KG + DL
34 insomnia (disease) KG + DL
35 idiopathic and/or familial pulmonary arterial hypertension KG + DL
36 gastrointestinal hamartoma KG + DL
37 intrinsic asthma KG + DL
38 pneumocystosis KG + DL
39 uterine polyp KG + DL
40 intracranial arteriosclerosis KG + DL
41 female breast carcinoma KG + DL
42 polyp of vocal cord KG + DL
43 polyp of middle ear KG + DL
44 lymphocytic hypereosinophilic syndrome KG + DL
45 collagenopathy KG + DL
46 epulis KG + DL
47 fibroepithelial polyp KG + DL
48 polyp of frontal sinus KG + DL
49 polyp of ureter KG + DL
50 neoplastic polyp KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.